Xenetic Biosciences
XBIO
9 hedge funds and large institutions have $250K invested in Xenetic Biosciences in 2025 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
2.82% less ownership
Funds ownership: 6.98% → 4.16% (-2.8%)
15% less capital invested
Capital invested by funds: $293K → $250K (-$42.9K)
31% less funds holding
Funds holding: 13 → 9 (-4)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
S
Sachetta
Lynnfield,
Massachusetts
|
+$13.3K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$6 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$66.3K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$45.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$6.61K |
| 4 |
Renaissance Technologies
New York
|
-$5.82K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$1.37K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $97K | -$5.82K | -2,014 | -8% |
|
|
S
2
Sachetta
Lynnfield,
Massachusetts
| $59.8K | +$13.3K | +4,593 | +43% |
|
|
LGF
3
LGT Group Foundation
Vaduz,
Liechtenstein
| $41.1K | – | – | – |
|
|
4
Geode Capital Management
Boston,
Massachusetts
| $41.1K | -$1.37K | -475 | -4% |
|
|
JEST
5
JTC Employer Solutions Trustee
St Helier,
Jersey
| $11K | – | – | – |
|
|
6
Bank of America
Charlotte,
North Carolina
| $51 | +$6 | +2 | +18% |
|
|
SS
7
SBI Securities
Tokyo,
Japan
| $20 | – | – | – |
|
8
Morgan Stanley
New York
| $16 | – | – | – |
|
|
DWM
9
Darwin Wealth Management
Tampa,
Florida
| $7 | – | – | – |
|
|
10
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$66.3K | -25,388 | Closed |
|
|
11
Citadel Advisors
Miami,
Florida
| – | -$45.1K | -17,289 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$6.61K | -2,531 | Closed |
|
13
Barclays
London,
United Kingdom
| – | -$585 | -224 | Closed |
|
XBIO Hedge Fund Activity: Q2 2025 in Review
9 of the 7,604 institutional investors tracked by Wall St. Rank reported a position in Xenetic Biosciences (XBIO) for Q2 2025, worth a combined $250K — down 15% from $293K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of XBIO and 0 opened new positions — a net loss of 4 holders — while 2 trimmed existing stakes and 2 added.
The largest buyer was Sachetta, adding an estimated $13.3K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $66.3K sold.
- 9 institutional investors held Xenetic Biosciences (XBIO) as of Q2 2025, down from 13 in Q1 2025.
- Funds reported $250K of Xenetic Biosciences stock for Q2 2025, down 15% quarter-over-quarter.
- 0 funds opened new Xenetic Biosciences positions in Q2 2025 and 4 closed out, a net change of -4 holders.
- The largest Xenetic Biosciences buyer in Q2 2025 was Sachetta, an estimated $13.3K added.
- The largest Xenetic Biosciences seller in Q2 2025 was Susquehanna International Group, an estimated $66.3K sold.
Based on aggregated 13F filings for Q2 2025.